The Current Ratio as of December 2025 (TTM) for Andros Pharmaceuticals Co.,Ltd (6917.TWO) is 13.81

According to Andros Pharmaceuticals Co.,Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 13.81. This represents a change of -11.48% compared to the average of 15.60 of the last 4 quarters.

Andros Pharmaceuticals Co.,Ltd (6917.TWO) Historical Current Ratio (quarterly & annually)

How has 6917.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Andros Pharmaceuticals Co.,Ltd over the last ten years is 9.67. The current 13.81 Current Ratio has changed 14.17% with respect to the historical average. Over the past ten years (40 quarters), 6917.TWO's Current Ratio was at its highest in in the June 2024 quarter at 21.94. The Current Ratio was at its lowest in in the June 2023 quarter at 12.48.

Andros Pharmaceuticals Co.,Ltd (6917.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Andros Pharmaceuticals Co.,Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Andros Pharmaceuticals Co.,Ltd (6917.TWO) Average Current Ratio

How has 6917.TWO Current Ratio performed in the past?

The current Current Ratio of Andros Pharmaceuticals Co.,Ltd (6917.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Andros Pharmaceuticals Co.,Ltd (6917.TWO) Current Ratio vs. Peers

How is 6917.TWO’s Current Ratio compared to its peers?

Andros Pharmaceuticals Co.,Ltd’s Current Ratio is greater than SynCore Biotechnology Co.,Ltd (11.18), less than Eusol Biotech Co.,Ltd. (43.56), greater than LAUNXP Biomedical Co., Ltd (7.53), greater than NatureWise Biotech & Medicals Corporation (11.89), less than Bio Preventive Medicine Corp. (19.06), greater than Lukas Biomedical Inc. (1.21), greater than TCI GENE Inc. (5.74), less than LabTurbo Biotech Corporation (14.89), greater than BioLASCO Taiwan Co., Ltd. (2.48), greater than General Biologicals Corporation (1.32),

Build a custom stock screener for Andros Pharmaceuticals Co.,Ltd (6917.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Andros Pharmaceuticals Co.,Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Andros Pharmaceuticals Co.,Ltd (6917.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Andros Pharmaceuticals Co.,Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.